Results 1 to 10 of about 965,485 (298)

Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands [PDF]

open access: yesJournal of Nanobiotechnology
Neurodegenerative diseases are characterized by extensive loss of function or death of brain cells, hampering the life quality of patients. Brain-targeted drug delivery is challenging, with a low success rate this far.
Ricardo Moreira   +3 more
doaj   +6 more sources

A Novel Brain-Targeting Nanoparticle Loaded with Biatractylolide and Its Protective Effect on Alzheimer’s Disease [PDF]

open access: yesPharmaceuticals
Background: To enhance the bioavailability and neuroprotective efficacy of biatractylolide against Alzheimer’s disease by developing a novel Tween-80-modified pullulan–chenodeoxycholic acid nanoparticle as a delivery vehicle.
Qianmei Hu   +9 more
doaj   +2 more sources

Evaluation of Brain Targeting and Antipsychotic Activity of Nasally Administrated Ziprasidone Lipid–Polymer Hybrid Nanocarriers [PDF]

open access: yesPharmaceuticals, 2023
The feasibility of using lipid–polymer hybrid (LPH) nanocarriers as a potential platform for the intranasal delivery of ziprasidone (ZP), a second-generation antipsychotic, was explored.
Hadel A. Abo El-Enin   +6 more
doaj   +2 more sources

Intranasal Nanotransferosomal Gel for Quercetin Brain Targeting: I. Optimization, Characterization, Brain Localization, and Cytotoxic Studies [PDF]

open access: yesPharmaceutics, 2023
Numerous neurological disorders have a pathophysiology that involves an increase in free radical production in the brain. Quercetin (QER) is a nutraceutical compound that shields the brain against oxidative stress-induced neurodegeneration.
Mohammed H. Elkomy   +10 more
doaj   +2 more sources

PTX-loaded, polysorbate 80-functionalized brain-targeting pullulan nanoparticles for drug delivery [PDF]

open access: yesFrontiers in Pharmacology
Brain-targeted drug delivery remains a major challenge in pharmaceutical research. In this study, four types of polysorbate 80 and cholesterol-modified pullulan polymers (CHPP) were synthesized and self-assembled into nanoparticles (CHPP NPs) for brain ...
Huabing Yuan   +11 more
doaj   +2 more sources

Development and Evaluation of Nanosuspension Loaded Nanogel of Nortriptyline HCl for Brain Delivery

open access: yesEngineering Proceedings, 2023
Nanogel systems loaded with nanosuspension area promising approach tonose-to-brain delivery in order to reduce the dose and dosing frequency and also improve the bioavailability of the drug.
Akash J. Amkar   +2 more
doaj   +1 more source

Optical tissue clearing and machine learning can precisely characterize extravasation and blood vessel architecture in brain tumors

open access: yesCommunications Biology, 2021
Kostrikov et al. report a deficiency of transcardial perfusion in brain tumor vasculature, which leads to exaggeration of drug extravasation measurements.
Serhii Kostrikov   +10 more
doaj   +1 more source

Brain-Targeted Intranasal Delivery of Zotepine Microemulsion: Pharmacokinetics and Pharmacodynamics

open access: yesPharmaceutics, 2022
The purpose of our study was to improve the solubility, bioavailability, and efficacy of zotepine (ZTP) by brain-targeted intranasal delivery of microemulsion (ME) and its physicochemical properties, the pharmacokinetic and pharmacodynamic parameters ...
Sravanthi Reddy Pailla   +5 more
doaj   +1 more source

Lipid Nanocarriers Overlaid with Chitosan for Brain Delivery of Berberine via the Nasal Route

open access: yesPharmaceuticals, 2022
This research aimed to design, optimize, and evaluate berberine-laden nanostructured lipid carriers overlaid with chitosan (BER-CTS-NLCs) for efficient brain delivery via the intranasal route.
Hadel A. Abo El-Enin   +7 more
doaj   +1 more source

Intranasal Administration of Dolutegravir-Loaded Nanoemulsion-Based In Situ Gel for Enhanced Bioavailability and Direct Brain Targeting

open access: yesGels, 2023
Dolutegravir’s therapeutic effectiveness in the management of neuroAIDS is mainly limited by its failure to cross the blood–brain barrier. However, lipid-based nanovesicles such as nanoemulsions have demonstrated their potential for the brain targeting ...
Anroop B. Nair   +11 more
doaj   +1 more source

Home - About - Disclaimer - Privacy